{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:21:57Z","timestamp":1792783317421,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e0 degli Studi di Roma La Sapienza","id":[{"id":"https:\/\/ror.org\/02be6w209","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s11739-026-04399-7","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T19:36:11Z","timestamp":1780083371000},"page":"2141-2152","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Platelet activation and short-term rifaximin therapy in decompensated cirrhosis: a pilot randomized controlled study"],"prefix":"10.1007","volume":"21","author":[{"given":"Simone","family":"Di Cola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Maiorca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Stefanini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Sabetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"D\u2019Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Lapenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Castellani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio Francesco","family":"Romiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Cangemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliviero","family":"Riggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2100-5682","authenticated-orcid":false,"given":"Valeria","family":"Raparelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Merli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Basili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"issue":"5","key":"4399_CR1","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.jhep.2023.01.010","volume":"78","author":"A Zanetto","year":"2023","unstructured":"Zanetto A, Northup P, Roberts L, Senzolo M (2023) Haemostasis in cirrhosis: understanding destabilising factors during acute decompensation. J Hepatol 78(5):1037\u20131047. https:\/\/doi.org\/10.1016\/j.jhep.2023.01.010","journal-title":"J Hepatol"},{"issue":"8","key":"4399_CR2","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/S2468-1253(24)00078-5","volume":"9","author":"S Piano","year":"2024","unstructured":"Piano S, Bunchorntavakul C, Marciano S, Rajender Reddy K (2024) Infections in cirrhosis. Lancet Gastroenterol Hepatol 9(8):745\u2013757. https:\/\/doi.org\/10.1016\/S2468-1253(24)00078-5","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"4399_CR3","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jhep.2022.09.005","volume":"78","author":"A Zanetto","year":"2023","unstructured":"Zanetto A, Pelizzaro F, Campello E et al (2023) Severity of systemic inflammation is the main predictor of ACLF and bleeding in individuals with acutely decompensated cirrhosis. J Hepatol 78(2):301\u2013311. https:\/\/doi.org\/10.1016\/j.jhep.2022.09.005","journal-title":"J Hepatol"},{"issue":"6","key":"4399_CR4","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.jhep.2014.08.010","volume":"61","author":"A Albillos","year":"2014","unstructured":"Albillos A, Lario M, \u00c1lvarez-Mon M (2014) Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance. J Hepatol 61(6):1385\u20131396. https:\/\/doi.org\/10.1016\/j.jhep.2014.08.010","journal-title":"J Hepatol"},{"issue":"1","key":"4399_CR5","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1053\/jhep.2003.50038","volume":"37","author":"A Albillos","year":"2003","unstructured":"Albillos A, la Hera A, Gonz\u00e1lez M et al (2003) Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatology 37(1):208\u2013217. https:\/\/doi.org\/10.1053\/jhep.2003.50038","journal-title":"Hepatology"},{"issue":"11","key":"4399_CR6","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1055\/A-2091-7006","volume":"123","author":"ATA Sachetto","year":"2023","unstructured":"Sachetto ATA, Mackman N (2023) Monocyte tissue factor expression: lipopolysaccharide induction and roles in pathological activation of coagulation. Thromb Haemost 123(11):1017\u20131033. https:\/\/doi.org\/10.1055\/A-2091-7006","journal-title":"Thromb Haemost"},{"key":"4399_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2022.100493","author":"A Zanetto","year":"2022","unstructured":"Zanetto A, Campello E, Bulato C et al (2022) Global hemostatic profiling in patients with decompensated cirrhosis and bacterial infections. JHEP Rep. https:\/\/doi.org\/10.1016\/j.jhepr.2022.100493","journal-title":"JHEP Rep"},{"issue":"9","key":"4399_CR8","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1111\/jth.15797","volume":"20","author":"EG Driever","year":"2022","unstructured":"Driever EG, Magaz M, Adelmeijer J et al (2022) The portal vein in patients with cirrhosis is not an excessively inflammatory or hypercoagulable vascular bed, a prospective cohort study. J Thromb Haemost 20(9):2075\u20132082. https:\/\/doi.org\/10.1111\/jth.15797","journal-title":"J Thromb Haemost"},{"issue":"2","key":"4399_CR9","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/HEP.28853","volume":"65","author":"V Raparelli","year":"2017","unstructured":"Raparelli V, Basili S, Carnevale R et al (2017) Low-grade endotoxemia and platelet activation in cirrhosis. Hepatology 65(2):571\u2013581. https:\/\/doi.org\/10.1002\/HEP.28853","journal-title":"Hepatology"},{"issue":"3","key":"4399_CR10","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","volume":"72","author":"A Albillos","year":"2020","unstructured":"Albillos A, de Gottardi A, Rescigno M (2020) The gut-liver axis in liver disease: pathophysiological basis for therapy. J Hepatol 72(3):558\u2013577. https:\/\/doi.org\/10.1016\/j.jhep.2019.10.003","journal-title":"J Hepatol"},{"issue":"3","key":"4399_CR11","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/J.DLD.2023.09.012","volume":"56","author":"A Dalbeni","year":"2024","unstructured":"Dalbeni A, Cattazzo F, De Marco L et al (2024) Bacterial infections as a risk factor for non-neoplastic portal vein thrombosis development in cirrhotic patients. Dig Liver Dis 56(3):477\u2013483. https:\/\/doi.org\/10.1016\/J.DLD.2023.09.012","journal-title":"Dig Liver Dis"},{"key":"4399_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/J.DLD.2025.03.024","author":"S Di Cola","year":"2025","unstructured":"Di Cola S, Gazda J, Fonte S et al (2025) The impact of bacterial infection on the risk of portal vein thrombosis development in patients with cirrhosis: a post-hoc analysis. Dig Liver Dis. https:\/\/doi.org\/10.1016\/J.DLD.2025.03.024","journal-title":"Dig Liver Dis"},{"issue":"2","key":"4399_CR13","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/0016-5085(95)90342-9","volume":"109","author":"F Violi","year":"1995","unstructured":"Violi F, Ferro D, Basili S et al (1995) Association between low-grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosis. Gastroenterology 109(2):531\u2013539. https:\/\/doi.org\/10.1016\/0016-5085(95)90342-9","journal-title":"Gastroenterology"},{"key":"4399_CR14","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.07.018","author":"E Villa","year":"2012","unstructured":"Villa E, Camm\u00e0 C, Marietta M et al (2012) Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis. Gastroenterology. https:\/\/doi.org\/10.1053\/j.gastro.2012.07.018","journal-title":"Gastroenterology"},{"issue":"12","key":"4399_CR15","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1111\/jth.15526","volume":"19","author":"AL Frelinger","year":"2021","unstructured":"Frelinger AL, Rivera J, Connor DE et al (2021) Consensus recommendations on flow cytometry for the assessment of inherited and acquired disorders of platelet number and function: communication from the ISTH SSC Subcommittee on Platelet Physiology. J Thromb Haemost 19(12):3193\u20133202. https:\/\/doi.org\/10.1111\/jth.15526","journal-title":"J Thromb Haemost"},{"issue":"2","key":"4399_CR16","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","volume":"69","author":"P Angeli","year":"2018","unstructured":"Angeli P, Bernardi M, Villanueva C et al (2018) EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol 69(2):406\u2013460. https:\/\/doi.org\/10.1016\/j.jhep.2018.03.024","journal-title":"J Hepatol"},{"issue":"4","key":"4399_CR17","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/JGH3.12152","volume":"3","author":"CR Khatua","year":"2019","unstructured":"Khatua CR, Sahu SK, Barik RK et al (2019) Validation of International Club of Ascites subclassification of stage 1 acute kidney injury in chronic liver disease. JGH Open 3(4):290\u2013294. https:\/\/doi.org\/10.1002\/JGH3.12152","journal-title":"JGH Open"},{"issue":"2","key":"4399_CR18","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/HEP.27210","volume":"60","author":"H Vilstrup","year":"2014","unstructured":"Vilstrup H, Amodio P, Bajaj J et al (2014) Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver. Hepatology 60(2):715\u2013735. https:\/\/doi.org\/10.1002\/HEP.27210","journal-title":"Hepatology"},{"issue":"5","key":"4399_CR19","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.dld.2016.02.008","volume":"48","author":"A Andriulli","year":"2016","unstructured":"Andriulli A, Tripodi A, Angeli P et al (2016) Hemostatic balance in patients with liver cirrhosis: report of a consensus conference. Dig Liver Dis 48(5):455\u2013467. https:\/\/doi.org\/10.1016\/j.dld.2016.02.008","journal-title":"Dig Liver Dis"},{"issue":"1","key":"4399_CR20","doi-asserted-by":"publisher","first-page":"E108","DOI":"10.1097\/MEG.0000000000001982","volume":"33","author":"F Nery","year":"2021","unstructured":"Nery F, Carneiro P, Correia S et al (2021) Systemic inflammation as a risk factor for portal vein thrombosis in cirrhosis: a prospective longitudinal study. Eur J Gastroenterol Hepatol 33(1):E108\u2013E113. https:\/\/doi.org\/10.1097\/MEG.0000000000001982","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"4399_CR21","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1084\/JEM.20112322","volume":"209","author":"ML von Br\u00fchl","year":"2012","unstructured":"von Br\u00fchl ML, Stark K, Steinhart A et al (2012) Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med 209(4):819\u2013835. https:\/\/doi.org\/10.1084\/JEM.20112322","journal-title":"J Exp Med"},{"key":"4399_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/JLEUKO\/QIAE222","author":"JMN Teo","year":"2025","unstructured":"Teo JMN, Chen W, Ling GS (2025) Neutrophil plasticity in liver diseases. J Leukoc Biol. https:\/\/doi.org\/10.1093\/JLEUKO\/QIAE222","journal-title":"J Leukoc Biol"},{"key":"4399_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/JCLA.24433","author":"Y Xing","year":"2022","unstructured":"Xing Y, Jiang Y, Xing S et al (2022) Neutrophil extracellular traps are associated with enhanced procoagulant activity in liver cirrhosis patients with portal vein thrombosis. J Clin Lab Anal. https:\/\/doi.org\/10.1002\/JCLA.24433","journal-title":"J Clin Lab Anal"},{"key":"4399_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/PETR.13390","author":"N Bonnet","year":"2019","unstructured":"Bonnet N, Paul J, Helleputte T et al (2019) Novel insights into the assessment of risk of upper gastrointestinal bleeding in decompensated cirrhotic children. Pediatr Transplant. https:\/\/doi.org\/10.1111\/PETR.13390","journal-title":"Pediatr Transplant"},{"key":"4399_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0200364","author":"D Eyraud","year":"2018","unstructured":"Eyraud D, Suner L, Dupont A et al (2018) Evolution of platelet functions in cirrhotic patients undergoing liver transplantation: a prospective exploration over a month. PLoS ONE. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0200364","journal-title":"PLoS ONE"},{"issue":"5","key":"4399_CR26","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1080\/09537104.2017.1349308","volume":"29","author":"PJ Vinholt","year":"2018","unstructured":"Vinholt PJ, Hvas AM, Nielsen C et al (2018) Reduced platelet activation and platelet aggregation in patients with alcoholic liver cirrhosis. Platelets 29(5):520\u2013527. https:\/\/doi.org\/10.1080\/09537104.2017.1349308","journal-title":"Platelets"},{"issue":"6","key":"4399_CR27","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.clinre.2016.03.008","volume":"40","author":"P Wosiewicz","year":"2016","unstructured":"Wosiewicz P, \u017borniak M, Hartleb M et al (2016) Portal vein thrombosis in cirrhosis is not associated with intestinal barrier disruption or increased platelet aggregability. Clin Res Hepatol Gastroenterol 40(6):722\u2013729. https:\/\/doi.org\/10.1016\/j.clinre.2016.03.008","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"4","key":"4399_CR28","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.thromres.2009.06.011","volume":"124","author":"B J\u00fcttner","year":"2009","unstructured":"J\u00fcttner B, Brock J, Wei\u00dfig A et al (2009) Dependence of platelet function on underlying liver disease in orthotopic liver transplantation. Thromb Res 124(4):433\u2013438. https:\/\/doi.org\/10.1016\/j.thromres.2009.06.011","journal-title":"Thromb Res"},{"key":"4399_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS18051016","author":"NS Nielsen","year":"2017","unstructured":"Nielsen NS, Jespersen S, Gaardbo JC et al (2017) Impaired platelet aggregation and rebalanced hemostasis in patients with chronic hepatitis C virus infection. Int J Mol Sci. https:\/\/doi.org\/10.3390\/IJMS18051016","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4399_CR30","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.jhep.2022.03.009","volume":"77","author":"A Zanetto","year":"2022","unstructured":"Zanetto A, Campello E, Bulato C et al (2022) Increased platelet aggregation in patients with decompensated cirrhosis indicates higher risk of further decompensation and death. J Hepatol 77(3):660\u2013669. https:\/\/doi.org\/10.1016\/j.jhep.2022.03.009","journal-title":"J Hepatol"},{"issue":"6","key":"4399_CR31","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.jhep.2011.06.008","volume":"55","author":"F Violi","year":"2011","unstructured":"Violi F, Basili S, Raparelli V, Chowdary P, Gatt A, Burroughs AK (2011) Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction? J Hepatol 55(6):1415\u20131427. https:\/\/doi.org\/10.1016\/j.jhep.2011.06.008","journal-title":"J Hepatol"},{"issue":"2","key":"4399_CR32","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/0016-5085(92)90859-W","volume":"103","author":"G Laffi","year":"1992","unstructured":"Laffi G, Marra F, Gresele P et al (1992) Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregation. Gastroenterology 103(2):641\u2013646. https:\/\/doi.org\/10.1016\/0016-5085(92)90859-W","journal-title":"Gastroenterology"},{"issue":"16","key":"4399_CR33","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1182\/BLOODADVANCES.2018017756","volume":"2","author":"CW Smith","year":"2018","unstructured":"Smith CW, Raslan Z, Parfitt L et al (2018) TREM-like transcript 1: a more sensitive marker of platelet activation than P-selectin in humans and mice. Blood Adv 2(16):2072\u20132078. https:\/\/doi.org\/10.1182\/BLOODADVANCES.2018017756","journal-title":"Blood Adv"},{"issue":"23","key":"4399_CR34","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1182\/BLOOD-2018-03-841593","volume":"132","author":"J Morales-Ort\u00edz","year":"2018","unstructured":"Morales-Ort\u00edz J, Deal V, Reyes F et al (2018) Platelet-derived TLT-1 is a prognostic indicator in ALI\/ARDS and prevents tissue damage in the lungs in a mouse model. Blood 132(23):2495\u20132505. https:\/\/doi.org\/10.1182\/BLOOD-2018-03-841593","journal-title":"Blood"},{"issue":"7","key":"4399_CR35","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/NG.604","volume":"42","author":"AD Johnson","year":"2010","unstructured":"Johnson AD, Yanek LR, Chen MH et al (2010) Genome-wide meta-analyses identifies seven loci associated with platelet aggregation in response to agonists. Nat Genet 42(7):608\u2013613. https:\/\/doi.org\/10.1038\/NG.604","journal-title":"Nat Genet"},{"key":"4399_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0060042","author":"JS Bajaj","year":"2013","unstructured":"Bajaj JS, Heuman DM, Sanyal AJ et al (2013) Modulation of the metabiome by Rifaximin in patients with cirrhosis and minimal hepatic encephalopathy. PLoS ONE. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0060042","journal-title":"PLoS ONE"},{"issue":"47","key":"4399_CR37","doi-asserted-by":"publisher","first-page":"8355","DOI":"10.3748\/WJG.V23.I47.8355","volume":"23","author":"K Kaji","year":"2017","unstructured":"Kaji K, Takaya H, Saikawa S et al (2017) Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity. World J Gastroenterol 23(47):8355\u20138366. https:\/\/doi.org\/10.3748\/WJG.V23.I47.8355","journal-title":"World J Gastroenterol"},{"issue":"9","key":"4399_CR38","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1210\/JS.2019-00148","volume":"3","author":"BS Finlin","year":"2019","unstructured":"Finlin BS, Zhu B, Boyechko T et al (2019) Effect of Rifaximin treatment on endotoxemia and insulin sensitivity in humans. J Endocr Soc 3(9):1641\u20131651. https:\/\/doi.org\/10.1210\/JS.2019-00148","journal-title":"J Endocr Soc"},{"key":"4399_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/ANTIBIOTICS9040145","author":"K Kaji","year":"2020","unstructured":"Kaji K, Saikawa S, Takaya H et al (2020) Rifaximin alleviates endotoxemia with decreased serum levels of soluble CD163 and mannose receptor and partial modification of gut microbiota in cirrhotic patients. Antibiotics. https:\/\/doi.org\/10.3390\/ANTIBIOTICS9040145","journal-title":"Antibiotics"},{"key":"4399_CR40","doi-asserted-by":"publisher","DOI":"10.1001\/JAMA.2024.27441","author":"E Pose","year":"2025","unstructured":"Pose E, Jim\u00e9nez C, Zaccherini G et al (2025) Simvastatin and Rifaximin in decompensated cirrhosis a randomized clinical trial. JAMA. https:\/\/doi.org\/10.1001\/JAMA.2024.27441","journal-title":"JAMA"},{"issue":"2","key":"4399_CR41","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jhep.2021.09.010","volume":"76","author":"VC Patel","year":"2022","unstructured":"Patel VC, Lee S, McPhail MJW et al (2022) Rifaximin-\u03b1 reduces gut-derived inflammation and mucin degradation in cirrhosis and encephalopathy: RIFSYS randomised controlled trial. J Hepatol 76(2):332\u2013342. https:\/\/doi.org\/10.1016\/j.jhep.2021.09.010","journal-title":"J Hepatol"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-026-04399-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-026-04399-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-026-04399-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:33:30Z","timestamp":1789540410000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-026-04399-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["4399"],"URL":"https:\/\/doi.org\/10.1007\/s11739-026-04399-7","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"8 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G.F.R. reports consultancy for Boehringer Ingelheim and educational grant from Anthos, outside the scope of this study; no fees were directly received personally. S.B. has received a research grant from MSD, outside the scope of this study. The other authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been conducted according to the principles stated in the Declaration of Helsinki and after approval by the local ethical committee at Sapienza University of Rome\u00a0(Ethical Committee number Rif. 4438).\u00a0All the participants provided their written informed consent to participate in this study.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}